Literature DB >> 19952284

Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa.

Xue Cai1, Shannon M Conley, Zack Nash, Steven J Fliesler, Mark J Cooper, Muna I Naash.   

Abstract

The purpose of the present study was to test the therapeutic efficiency and safety of compacted-DNA nanoparticle-mediated gene delivery into the subretinal space of a juvenile mouse model of retinitis pigmentosa. Nanoparticles containing the mouse opsin promoter and wild-type mouse Rds gene were injected subretinally into mice carrying a haploinsufficiency mutation in the retinal degeneration slow (rds(+ or -)) gene at postnatal day (P)5 and 22. Control mice were either injected with saline, injected with uncompacted naked plasmid DNA carrying the Rds gene, or remained untreated. Rds mRNA levels peaked at postinjection day 2 to 7 (PI-2 to PI-7) for P5 injections, stabilized at levels 2-fold higher than in uninjected controls for both P5 and P22 injections, and remained elevated at the latest time point examined (PI-120). Rod function (measured by electroretinography) showed modest but statistically significant improvement compared with controls after both P5 and P22 injections. Cone function in nanoparticle-injected eyes reached wild-type levels for both ages of injections, indicating full prevention of cone degeneration. Ultrastructural examination at PI-120 revealed significant improvement in outer segment structures in P5 nanoparticle-injected eyes, while P22 injection had a modest structural improvement. There was no evidence of macrophage activation or induction of IL-6 or TNF-alpha mRNA in P5 or P22 nanoparticle-dosed eyes at either PI-2 or PI-30. Thus, compacted-DNA nanoparticles can efficiently and safely drive gene expression in both mitotic and postmitotic photoreceptors and retard degeneration in this model. These findings, using a clinically relevant treatment paradigm, illustrate the potential for application of nanoparticle-based gene replacement therapy for treatment of human retinal degenerations.-Cai, X., Conley, S. M., Nash, Z., Fliesler, S. J., Cooper, M. J., Naash, M. I. Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19952284      PMCID: PMC2845431          DOI: 10.1096/fj.09-139147

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  46 in total

1.  Characterization of peripherin/rds and rom-1 transport in rod photoreceptors of transgenic and knockout animals.

Authors:  Edwin S Lee; Beth Burnside; John G Flannery
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

2.  Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles.

Authors:  T L Fink; P J Klepcyk; S M Oette; C R Gedeon; S L Hyatt; T H Kowalczyk; R C Moen; M J Cooper
Journal:  Gene Ther       Date:  2006-03-09       Impact factor: 5.250

3.  Genetic supplementation of RDS alleviates a loss-of-function phenotype in C214S model of retinitis pigmentosa.

Authors:  May Nour; Steven J Fliesler; Muna I Naash
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 4.  The role of Rds in outer segment morphogenesis and human retinal disease.

Authors:  Rafal Farjo; Muna I Naash
Journal:  Ophthalmic Genet       Date:  2006-12       Impact factor: 1.803

Review 5.  Vectors for airway gene delivery.

Authors:  Pamela B Davis; Mark J Cooper
Journal:  AAPS J       Date:  2007-01-19       Impact factor: 4.009

6.  Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy.

Authors:  R R Ali; G M Sarra; C Stephens; M D Alwis; J W Bainbridge; P M Munro; S Fauser; M B Reichel; C Kinnon; D M Hunt; S S Bhattacharya; A J Thrasher
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

7.  Efficiency of lentiviral transduction during development in normal and rd mice.

Authors:  Jijing Pang; Mei Cheng; Shannon E Haire; Edward Barker; Vicente Planelles; Janet C Blanks
Journal:  Mol Vis       Date:  2006-07-11       Impact factor: 2.367

8.  Effect of Rds abundance on cone outer segment morphogenesis, photoreceptor gene expression, and outer limiting membrane integrity.

Authors:  Rafal Farjo; Steven J Fliesler; Muna I Naash
Journal:  J Comp Neurol       Date:  2007-10-20       Impact factor: 3.215

9.  Late-onset cone photoreceptor degeneration induced by R172W mutation in Rds and partial rescue by gene supplementation.

Authors:  Shannon Conley; May Nour; Steven J Fliesler; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-12       Impact factor: 4.799

10.  Efficient non-viral ocular gene transfer with compacted DNA nanoparticles.

Authors:  Rafal Farjo; Jeff Skaggs; Alexander B Quiambao; Mark J Cooper; Muna I Naash
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

View more
  58 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  A 350 bp region of the proximal promoter of Rds drives cell-type specific gene expression.

Authors:  Xue Cai; Shannon M Conley; Tong Cheng; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Exp Eye Res       Date:  2010-05-04       Impact factor: 3.467

3.  ROM1 contributes to phenotypic heterogeneity in PRPH2-associated retinal disease.

Authors:  Daniel Strayve; Mustafa S Makia; Mashal Kakakhel; Haarthi Sakthivel; Shannon M Conley; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Hum Mol Genet       Date:  2020-09-29       Impact factor: 6.150

4.  Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling.

Authors:  Yunzhou Dong; Xue Cai; Yong Wu; Yanjun Liu; Lin Deng; Hong Chen
Journal:  J Nat Sci       Date:  2017-01

Review 5.  AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.

Authors:  Zongchao Han; Shannon M Conley; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-10       Impact factor: 4.799

6.  Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cells.

Authors:  Adarsha Koirala; Rasha S Makkia; Mark J Cooper; Muna I Naash
Journal:  Biomaterials       Date:  2011-09-01       Impact factor: 12.479

Review 7.  Nanocarriers of nanotechnology in retinal diseases.

Authors:  Ali M Al-Halafi
Journal:  Saudi J Ophthalmol       Date:  2014-03-05

Review 8.  Exciting directions in glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman
Journal:  Can J Ophthalmol       Date:  2014-12       Impact factor: 1.882

9.  Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy.

Authors:  Zongchao Han; Junjing Guo; Shannon M Conley; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

10.  The potential of nanomedicine therapies to treat neovascular disease in the retina.

Authors:  Krysten M Farjo; Jian-Xing Ma
Journal:  J Angiogenes Res       Date:  2010-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.